Association of hypocalcemia with congenital heart disease in 22q11.2 deletion syndrome

Hypocalcemia is one of the cardinal features of the chromosome 22q11.2 deletion syndrome (22q11.2DS), the most common cause of DiGeorge syndrome. Hypocalcemia and other features of 22q11.2DS including congenital heart disease (CHD) are primarily ascribed to problems with morphogenesis and function of the pharyngeal arch system derivatives including the parathyroid glands, the aortic arch, and the cardiac outflow tract. In light of the aforementioned embryology, we hypothesized that hypocalcemia would be identified more frequently in those patients with 22q11.2DS and CHD. We conducted a retrospective IRB approved chart review on 1,300 subjects with 22q11.2DS evaluated at the Children's Hospital of Philadelphia. χ2 test was used to evaluate the statistical significance of differences in hypocalcemia between the two groups. Eight hundred fifty‐two patients had calcium levels available for review. Of these, 466 (54.69%) had a history of hypocalcemia and 550 (64.55%) had CHD. Of those with CHD, 343 (62.36%) had a history of hypocalcemia, and of those without CHD, only 123 (40.73%) had a history of hypocalcemia. Thus, the frequency of diagnosed hypocalcemia was greater in patients with 22q11.2DS and CHD as compared to those without CHD (p < .001). We also analyzed age of onset of hypocalcemia and found that 66.47% of CHD/hypocalcemia group had neonatal/infantile hypocalcemia versus 43.09% in the non‐CHD/hypocalcemia group. In our large cohort of patients with 22q11.2DS, the prevalence of diagnosed hypocalcemia is elevated among patients with CHD, in whom it is more likely to be diagnosed during the neonatal/infancy period.

[1]  T. Nakanishi,et al.  Clinical manifestations and frequency of hypocalcemia in 22q11.2 deletion syndrome , 2015, Pediatrics international : official journal of the Japan Pediatric Society.

[2]  Peter J. Scambler,et al.  22q11.2 deletion syndrome. , 2015, Nature reviews. Disease primers.

[3]  K. Choy,et al.  Prevalence of recurrent pathogenic microdeletions and microduplications in over 9500 pregnancies , 2015, Prenatal diagnosis.

[4]  E. Goldmuntz,et al.  22q11.2 Deletion syndrome is associated with perioperative outcome in tetralogy of Fallot. , 2013, The Journal of thoracic and cardiovascular surgery.

[5]  Manish Jain,et al.  Chromosome 22q11.2 microdeletion in monozygotic twins with discordant phenotype and deletion size , 2012, Molecular Cytogenetics.

[6]  Yibing Ding,et al.  Influence of Chromosome 22q11.2 Microdeletion on Postoperative Calcium Level After Cardiac-Correction Surgery , 2011, Pediatric Cardiology.

[7]  E. Zackai,et al.  Parathyroid hormone reserve in 22q11.2 deletion syndrome , 2008, Genetics in Medicine.

[8]  H. Yoo,et al.  Endocrine Manifestations of Chromosome 22q11.2 Microdeletion Syndrome , 2005, Hormone Research in Paediatrics.

[9]  K. Sullivan.  The clinical, immunological, and molecular spectrum of chromosome 22q11.2 deletion syndrome and DiGeorge syndrome , 2004, Current opinion in allergy and clinical immunology.

[10]  Lorenzo D Botto,et al.  A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population. , 2003, Pediatrics.

[11]  P. Scambler.  The 22q11 deletion syndromes. , 2000, Human molecular genetics.

[12]  A. Green,et al.  Spectrum of clinical features associated with interstitial chromosome 22q11 deletions: a European collaborative study. , 1997, Journal of medical genetics.

[13]  Joseph P. Near,et al.  How to cite this article , 2011 .

[14]  S. Weinzimer.  Endocrine aspects of the 22q11.2 deletion syndrome , 2001, Genetics in Medicine.

[15]  E. Zackai,et al.  Phenotype of the 22q11.2 deletion in individuals identified through an affected relative: Cast a wide FISHing net! , 2001, Genetics in Medicine.

[16]  E. Zackai,et al.  The Philadelphia story: the 22q11.2 deletion: report on 250 patients. , 1999, Genetic counseling.